Follow the people · Insider
Shelly Wong
Shelly Wong files insider transactions with the SEC as a svp, finance and cao of Alx Oncology Holdings (ALXO). We hold 5 disclosed purchases and sales filed since 5 May 2021, 2 of them in the last 90 days.
- Files forALXO
- Disclosed buys and sells5 in all, 2 in the last 90 days
- Last disclosure18 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 3 May 2020 — 17 August 2026SVP, Finance and CAO · Alx Oncology Holdings (ALXO)39 Form 4 lines · source: SEC Form 4
Everything they disclosed
39 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 573 shares of Alx Oncology HoldingsSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- ▼ sold on the open market 1,404 shares of Alx Oncology HoldingsSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- ▼ sold on the open market 903 shares of Alx Oncology HoldingsSEC Form 423 March 2026Common Stock · traded 19 March 2026 · filed 23 March 2026
- ▼ sold on the open market 903 shares of Alx Oncology HoldingsSEC Form 423 March 2026Common Stock · traded 19 March 2026 · filed 23 March 2026
- ▼ sold on the open market 565 shares of Alx Oncology HoldingsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- ▼ sold on the open market 565 shares of Alx Oncology HoldingsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- was granted 192,000 shares of Alx Oncology Holdings (a derivative holding)SEC Form 428 January 2026Stock option (right to buy) · traded 26 January 2026 · filed 28 January 2026
- was granted 192,000 shares of Alx Oncology Holdings (a derivative holding)SEC Form 428 January 2026Stock option (right to buy) · traded 26 January 2026 · filed 28 January 2026
- ▼ sold on the open market 3,925 shares of Alx Oncology HoldingsSEC Form 47 January 2026Common Stock · traded 6 January 2026 · filed 7 January 2026
- ▼ sold on the open market 3,925 shares of Alx Oncology HoldingsSEC Form 47 January 2026Common Stock · traded 6 January 2026 · filed 7 January 2026
- was granted 140,000 shares of Alx Oncology Holdings (a derivative holding)SEC Form 416 October 2025Employee Stock Option (right to buy) · traded 14 October 2025 · filed 16 October 2025
- ▼ sold on the open market 611 shares of Alx Oncology HoldingsSEC Form 419 August 2025Common Stock · traded 15 August 2025 · filed 19 August 2025
- ▼ sold on the open market 2,011 shares of Alx Oncology HoldingsSEC Form 48 July 2025Common Stock · traded 7 July 2025 · filed 8 July 2025
- ▼ sold on the open market 1,532 shares of Alx Oncology HoldingsSEC Form 41 July 2025Common Stock · traded 30 June 2025 · filed 1 July 2025
- was granted 90,000 shares of Alx Oncology Holdings (a derivative holding)SEC Form 415 April 2025Employee Stock Option (right to buy) · traded 11 April 2025 · filed 15 April 2025
- was granted 3,000 shares of Alx Oncology HoldingsSEC Form 418 March 2025Common Stock · traded 14 March 2025 · filed 18 March 2025
- ▼ sold on the open market 550 shares of Alx Oncology HoldingsSEC Form 421 February 2025Common Stock · traded 19 February 2025 · filed 21 February 2025
- was granted 112,000 shares of Alx Oncology Holdings (a derivative holding)SEC Form 423 January 2025Employee Stock Option (right to buy) · traded 21 January 2025 · filed 23 January 2025
- ▼ sold on the open market 2,221 shares of Alx Oncology HoldingsSEC Form 48 January 2025Common Stock · traded 6 January 2025 · filed 8 January 2025
- ▼ sold on the open market 1,426 shares of Alx Oncology HoldingsSEC Form 42 January 2025Common Stock · traded 30 December 2024 · filed 2 January 2025
- was granted 150,000 shares of Alx Oncology Holdings (a derivative holding)SEC Form 44 December 2024Employee Stock Option (right to buy) · traded 2 December 2024 · filed 4 December 2024
- ▼ sold on the open market 564 shares of Alx Oncology HoldingsSEC Form 416 August 2024Common Stock · traded 14 August 2024 · filed 16 August 2024
- ▼ sold on the open market 1,823 shares of Alx Oncology HoldingsSEC Form 49 July 2024Common Stock · traded 5 July 2024 · filed 9 July 2024
- ▼ sold on the open market 1,373 shares of Alx Oncology HoldingsSEC Form 43 July 2024Common Stock · traded 1 July 2024 · filed 3 July 2024
- was granted 35,000 shares of Alx Oncology Holdings (a derivative holding)SEC Form 416 February 2024Employee Stock Option (right to buy) · traded 14 February 2024 · filed 16 February 2024
- was granted 15,000 shares of Alx Oncology HoldingsSEC Form 416 February 2024Common Stock · traded 14 February 2024 · filed 16 February 2024
- ▼ sold on the open market 2,717 shares of Alx Oncology HoldingsSEC Form 45 January 2024Common Stock · traded 4 January 2024 · filed 5 January 2024
- ▼ sold on the open market 1,631 shares of Alx Oncology HoldingsSEC Form 43 January 2024Common Stock · traded 29 December 2023 · filed 3 January 2024
- was granted 36,000 shares of Alx Oncology Holdings (a derivative holding)SEC Form 427 July 2023Employee Stock Option (right to buy) · traded 25 July 2023 · filed 27 July 2023
- was granted 26,000 shares of Alx Oncology HoldingsSEC Form 427 July 2023Common Stock · traded 25 July 2023 · filed 27 July 2023
- ▼ sold on the open market 7,345 shares of Alx Oncology HoldingsSEC Form 47 July 2023Common Stock · traded 6 July 2023 · filed 7 July 2023
- ▼ sold on the open market 466 shares of Alx Oncology HoldingsSEC Form 45 July 2023Common Stock · traded 30 June 2023 · filed 5 July 2023
- ▼ sold on the open market 482 shares of Alx Oncology HoldingsSEC Form 43 January 2023Common Stock · traded 29 December 2022 · filed 3 January 2023
- was granted 36,000 shares of Alx Oncology Holdings (a derivative holding)SEC Form 49 August 2022Employee Stock Option (right to buy) · traded 5 August 2022 · filed 9 August 2022
- was granted 11,000 shares of Alx Oncology HoldingsSEC Form 49 August 2022Common Stock · traded 5 August 2022 · filed 9 August 2022
- was granted 50,000 shares of Alx Oncology HoldingsSEC Form 41 February 2022Common Stock · traded 28 January 2022 · filed 1 February 2022
- was granted 25,000 shares of Alx Oncology Holdings (a derivative holding)SEC Form 43 August 2021Employee Stock Option (right to buy) · traded 30 July 2021 · filed 3 August 2021
- was granted 125,000 shares of Alx Oncology Holdings (a derivative holding)SEC Form 419 May 2021Employee Stock Option (right to buy) · traded 3 May 2021 · filed 19 May 2021
- was granted 125,000 shares of Alx Oncology Holdings (a derivative holding)SEC Form 45 May 2021Employee Stock Option (right to buy) · traded 3 May 2020 · filed 5 May 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.